Top Markets
Coin of the day
Incannex Healthcare Limited Incannex Healthcare Limited

Incannex Healthcare Limited

IHL
株式のランク #33839
Established in Melbourne, Australia, in 2001, Incannex Healthcare Limited,... Established in Melbourne, Australia, in 2001, Incannex Healthcare Limited, which operated as Impression Healthcare Limited until its rebranding in June 2020, is dedicated to the research, development, and commercialization of pharmaceutical products and therapies derived from medicinal cannabinoids and psychedelics. Its offerings include a trio of ultrapure cannabinoid compounds: APIRx-1801 (tetrahydrocannabinol), APIRx-1802 (CBD), and APIRx-1803 (cannabigerol). The company's clinical pipeline features IHL-42X, which has concluded Phase IIa trials for obstructive sleep apnea, and Psi-GAD, currently in Phase IIa development for generalized anxiety disorder. Other compounds having successfully advanced through Phase IIa clinical trials include CanChew Plus for irritable bowel syndrome, APIRx-1601 for vitiligo, APIRx-1602 for psoriasis, and APIRx-1603 for atopic dermatitis. Additionally, MedChew Dronabinol has completed Phase Ia trials for chemotherapy-induced nausea and vomiting. Its pre-clinical portfolio is extensive, including IHL-675A, which has completed studies for inflammatory lung disease, rheumatoid arthritis, and inflammatory bowel disease, alongside IHL-216A for traumatic brain injury/concussion. A broad array of further candidates are actively undergoing pre-clinical investigation, such as MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpetic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for Crohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for cannabis addiction, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, and APIRx-1702 for dry eye syndrome.
株価
$0.0270762
最終同期: 2023-11-30
時価総額
$6.78M
変化(1日)
-0.66%
変化(1年)
0.00%
AU
取引 Incannex Healthcare Limited (IHL)

カテゴリー

Incannex Healthcare Limited(IHL)の株価履歴
終値の最高値: $0.03 (2023-11-01)

終値の最安値: $4.90 (2007-05-01)
Incannex Healthcare Limited の株価履歴(2007 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 -72.78%
2022 -65.89%
2021 218.18%
2020 169.28%
2019 233.32%
2018 4.26%
2017 -76.05%
2016 -11.66%
2015 37.57%
2014 -70.52%
2013 -83.29%
2012 -9.28%
2011 -46.22%
2010 142.62%
2009 121.48%
2008 -91.13%
2007 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$161.67 23.26%
DE
$35.97 20.03%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN